Cedric Dubois is an accomplished leader in the pharmaceutical and animal health industries, currently serving as AVP of Animal Health Small Molecules Manufacturing at Merck since March 2024, overseeing six manufacturing plants and a workforce of over 1,200. Previous roles include Interim Site General Manager at Biogen, where responsibilities included strategic oversight of production for clinical and commercial products, and Global Head of Corporate Partnerships/Vice President of Specialty Care at Sanofi, managing a $2 billion biologics portfolio and leading significant organizational integrations. Cedric's career began at Merial as a Senior Engineering Project Manager, demonstrating strong project management skills in high-value manufacturing facilities. Educational qualifications include an MBA from HKUST, a PMP certification, and two master's degrees in Pharmaceutical and Industrial Engineering.